Problematic Aspects of the Evaluation of the Epidemiological Effectiveness of Vaccination against Tick-BORNE Encephalitis

Por N. A. Penyevskaya, N. V. Rudakov, S. A. Rudakova
Publicado em 2018-10-01

OPEN ARTERIAL DUCT IN PREMATURE NEWBORN: TACTICS OF NEONATOLOGIST

Por D. S. Kryuchko, Ye. N. Baybarina, A. A. Rudakova
Publicado em 2011-01-01

Genospecies Diversity of Borrelia in Ixodes Ticks of the West Siberia

Por S. A. Rudakova, O. E. Teslova, N. E. Kaneshova, S. V. Shtrek, V. V. Yakimenko, N. A. Penyevskaya
Publicado em 2020-01-01

Romiplostim in thrombocytopenia treatment after allogeneic bone marrow transplantation

Por I. A. Lisukov, O. S. Uspenskaya, A. D. Kulagin, S. N. Bondarenko, T. A. Rudakova, O. A. Slesarchuk, B. V. Afanasyev
Publicado em 2014-07-01

Modern Condition of Natural foci Tick-Borne Infections in Altay Republic

Por S. A. Rudakova, L. D. Schuchinova, L. V. Schuchinov, N. V. Rudakov, A. F. Lubenko, M. G. Mal’Kova
Publicado em 2015-02-01

Intensity and Trends in Development of Epidemic Process of Ixodes Tick-Borne Borrelioses in the Russian Federation in 2002–2018 and Forecast for 2019

Por S. A. Rudakova, N. A. Pen’evskaya, N. V. Rudakov, N. D. Pakskina, D. A. Savel’ev, A. I. Blokh
Publicado em 2019-07-01

Modern Approches in the Study of Tick-Borne Infections Fod Based on Modular Methods

Por N. V. Rudakov, S. A. Rudakova, A. P. Efimova, O. M. Drozdova, A. F. Lubenko, Yu. A. Petrova, V. V. Yakimenko, V. A. Dedkov
Publicado em 2017-02-01

Epidemiological Situation on Tick-Borne Borreliosis in the Russian Federation in 2019 Compared to the Period of 2002–2018

Por S. A. Rudakova, N. A. Pen’evskaya, A. I. Blokh, D. A. Savel’ev, O. E. Teslova, N. E. Kaneshova, N. V. Rudakov, D. V. Trankvilevsky
Publicado em 2020-10-01

Review of the Epidemiological Situation on Ixodic Tick-Borne Borreliosis in the Russian Federation in 2010–2020 and Prognosis for 2021

Por S. A. Rudakova, N. A. Pen’evskaya, A. I. Blokh, N. V. Rudakov, D. V. Trankvilevsky, D. A. Savel’ev, O. E. Teslova, N. E. Kaneshova
Publicado em 2021-07-01

Chemoresistance of PRAME-expressing melanoma cell can be resolved with help of bortezomib

Por V. A. Misyurin, D. V. Kalenichenko, A. A. Rudakova, Yu. P. Finashutina, N. A. Lyzhko, V. V. Tikhonova, L. A. Kesaeva, O. N. Solopova, A. Е. Misyurina, A. N. Velikanov, M. А. Baryshnikovа, A. V. Misyurin
Publicado em 2019-01-01